Nepal Elimination of Trachoma Study

Status Withdrawn

Clinical Trial Summary

The main purpose of this study is to determine if ocular Chlamydia trachomatis infection can be eliminated in communities in Nepal following mass antibiotic distributions with azithromycin. The investigators will study both clinical trachoma and ocular C. trachomatis infection. The overall objective is to determine if the current World Health Organization (WHO) treatment strategy results in elimination of trachoma and infection.

1. The investigators hypothesize that 24 communities in Kanchanpur, Kailali, and Achham districts of Nepal which receive mass antibiotic treatments will achieve elimination of trachoma as a public health problem (clinical disease <5% in children 1-9 years old) more frequently than communities which have not received antibiotic treatments.

2. The investigators hypothesize that infection with C. trachomatis will be undetectable in all members within a community following mass treatment as determined by the most highly sensiti1. The investigators hypothesize that 24 communities in Kanchanpur, Kailali, and Achham districts of Nepal which receive mass antibiotic treatments will achieve elimination of trachoma as a public health problem (clinical disease <5% in children 1-9 years old) more frequently than communities which have not received antibiotic treatments.

2. The investigators hypothesize that infection with C. trachomatis will be undetectable in all members within a community following mass treatment as determined by the most highly sensitive nucleic acid amplification testing available (mRNA-based APTIMA and DNA-based AMPLICOR PCR).ve nucleic acid amplification testing available (mRNA-based APTIMA and DNA-based AMPLICOR PCR).

Clinical Trial Description

Here we evaluate whether ocular chlamydia infection and clinical trachoma are eliminated from 24 communities in western Nepal following a mass antibiotic distribution program. It is unknown if repeated treatments should continue or can be stopped thereby minimizing side effects and the high cost of medicine distribution. The investigators plan to randomize individuals to two groups to study the effects of a mass antibiotic distribution program: 1) treatment of antibiotics and 2) delayed treatment of antibiotics (after 4-6 months). ;

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

Trachoma

Clinical Trial Details

NCT number	NCT02176057
Study type	Interventional
Source	University of California, San Francisco
Contact
Status	Withdrawn
Phase	Phase 2/Phase 3
Start date	August 2014

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03676140` - Safety of Co-administration of IDA and Azithromycin for NTDs ( ComboNTDs )	Phase 3
Completed	`NCT01949454` - Fluorometholone as Ancillary Therapy for TT Surgery	N/A
Completed	`NCT01202331` - Tripartite International Research for the Elimination of Trachoma	Phase 4
Completed	`NCT05634759` - Enhancing the A in SAFE for Trachoma	Phase 4
Recruiting	`NCT04185402` - Azithromycin Reduction to Reach Elimination of Trachoma	Phase 4
Active, not recruiting	`NCT00886015` - Modified Instrumentation for Surgery to Correct Trichiasis	Phase 3
Completed	`NCT00792922` - Partnership for Rapid Elimination of Trachoma	Phase 4
Completed	`NCT00522860` - A Trial of Non-absorbable Versus Absorbable Sutures for Trichiasis Surgery	Phase 4
Completed	`NCT00221364` - Trachoma Elimination Follow-up	Phase 4
Completed	`NCT00322972` - Trachoma Amelioration in Northern Amhara (TANA)	Phase 4
Withdrawn	`NCT00286026` - Azithromycin in Control of Trachoma II	Phase 4
Completed	`NCT00347763` - Effect of Intensive Fly Control on Trachoma and Ocular Chlamydia Infection in Tanzania	Phase 4
Terminated	`NCT03997487` - Smartphone App for Taking Images of Conjunctivae	N/A
Terminated	`NCT04002726` - App-based Versus Slide-based Inter-grader Agreement (IGA) Test for Trachoma Graders	N/A
Not yet recruiting	`NCT06289647` - Azithromycin Reduction to Reach Elimination of Trachoma B	Phase 4
Withdrawn	`NCT02655432` - Performance of a Photoscreener for Vision Screening in a Haitian Pediatric Population	Phase 0
Completed	`NCT01767506` - A Surveillance and Azithromycin Treatment for Newcomers and Travelers Evaluation: The ASANTE Trial	N/A
Completed	`NCT00618449` - Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger	Phase 4
Completed	`NCT00356720` - Efficacy and Safety of 2 Dosing Regimens of T1225 Eye Drops 1.5% Versus Oral Azithromycin in Treatment of Trachoma	Phase 3
Completed	`NCT03813069` - Testing Insect Repellents Against Musca Sorbens, the Vector of Trachoma	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Nepal Elimination of Trachoma Study — NETS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms